Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy.
Beverley ChernDiluka PintoJeffrey Hy LumRajeev ParameswaranPublished in: Biomedicines (2024)
Nearly half of patients with ATC express PD-L1 and may be amenable to immunotherapy with pembrolizumab.